In conclusion, we used phage panning techniques to isolate anti-anxA1 antibodies with binding profiles designed to target anxA127-346, a truncated form of anxA1 that had previously been identified on the luminal surface of tumor endothelium. Here, ANXA1 is linked to neoplasm.